Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
PrECOG, LLC.
Fundación GECP
Bristol-Myers Squibb
University Medical Center Groningen
CHA University
City of Hope Medical Center
Peking University Cancer Hospital & Institute
Second Affiliated Hospital, School of Medicine, Zhejiang University
Sun Yat-sen University
Azienda Policlinico Umberto I
Aetion, Inc.
Aetion, Inc.
Swami Rama Himalayan University
University Medical Center Groningen
Ankara Etlik City Hospital
Shanghai Zhongshan Hospital
Peking University Third Hospital
Ain Shams University
University of California, San Diego
Sun Yat-sen University
Holy Name Medical Center, Inc.
European Lung Cancer Working Party
Sun Yat-sen University
Sungkyunkwan University
Grupo Oncologico Cooperativo Chileno de Investigation
Daiichi Sankyo
Xijing Hospital
University of Pisa
Wake Forest University Health Sciences
GlaxoSmithKline
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Ziekenhuis Oost-Limburg
First People's Hospital of Foshan
Roswell Park Cancer Institute
GlaxoSmithKline
Royal Marsden NHS Foundation Trust